Study seeks to predict which teens benefit from brain stimulation and therapy
NCT ID NCT07283419
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 163 teens with major depression to see if family factors (like conflict or closeness) and cognitive skills (like attention and planning) could predict how well they respond to a combination of repetitive transcranial magnetic stimulation (rTMS) and group cognitive behavioral therapy. The goal was to identify early clues that might help personalize treatment. The study is complete and focused on gathering knowledge, not testing a new cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- repetitive transcranial magnetic stimulation (rTMS) and group cognitive behavioral therapy
- What this could lead to
- If successful, this could help doctors personalize depression treatment for teens by identifying who will benefit most from combining rTMS with group therapy.
- What could go wrong
- This is a completed observational study, not a treatment trial, so it won't prove the therapy works—only which factors might predict response. Results may not apply to all teens with depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can tailored brain zaps beat standard therapy for depression?
- Can a new daily pill lift the fog of depression?
- Can a new pill outsmart depression? a trial puts KH607 to the test
- Depression's biological fingerprint: a quest for objective diagnosis and personalized treatment